Buy AOD-9604 Peptide in Australia
Buy AOD-9604 in Australia from Macropus Peptides in 2mg and 5mg vials. It is a 16 amino acid peptide modelled on the C-terminal end of human growth hormone, first developed in Melbourne and studied for its effects on fat metabolism in laboratory and animal research. Every vial holds the research-grade peptide as a lyophilised powder, sealed and labelled with compound, strength, lot number and storage temperature, and each lot has its own certificate of analysis. Both vials are priced and ready to order, and the 5mg vial costs about half as much per milligram. Unlike full growth hormone, it does not act as a growth hormone or raise IGF-1 in published research, which is why it is studied on its own. Order AOD-9604 online, add bacteriostatic water or dilute acetic acid for reconstitution, and your parcel is dispatched from Australian stock to any Australian address. AOD-9604 for sale to researchers aged 18 and over, strictly for in-vitro laboratory research and not for human or veterinary use.
| Compound | AOD-9604 |
|---|---|
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
AOD-9604 2mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy AOD-9604 Australia: 2mg and 5mg Vials
Macropus Peptides offers AOD-9604 Australia wide as 2mg and 5mg vials. It is a modified fragment of human growth hormone with a research history that began in Melbourne, and we supply it as research-grade freeze-dried peptide for laboratory study. Whichever size you pick, the peptide is identical: same source, same batch release, just a different fill.
AOD-9604 Australia: what the peptide is
This is a synthetic peptide of 16 amino acids. Its sequence is residues 177 to 191 of human growth hormone, the very end of the hormone's C-terminal tail, with an extra tyrosine added at the front; two cysteines in the chain are joined by a disulfide bond that holds it in a loop. The name comes from its original development code, and it is also described as a modified hGH fragment or Tyr-hGH 177-191. The peptide came out of Australian research in the 1990s into which part of growth hormone controls fat metabolism, and it was later developed by a Melbourne biotechnology company. It is not a growth hormone: it does not reproduce the growth-promoting actions of the full hormone.
AOD-9604 peptide Australia: how the fragment acts in lab studies
Full-length growth hormone affects growth, blood sugar and fat metabolism at once. Researchers found that the fat-metabolism activity could be traced to the C-terminal region, and this peptide was designed to keep that activity while leaving the rest behind. In fat cell and animal studies it was linked to increased breakdown of stored fat, known as lipolysis, and reduced formation of new fat, known as lipogenesis, without raising IGF-1 or affecting blood sugar the way whole growth hormone does. Studies in genetically modified mice pointed to a role for beta-3 adrenergic receptors in its action. Laboratories use it to study how growth hormone's metabolic effects can be separated from its growth effects.
AOD-9604 research: what the studies show
Its research record starts with work on synthetic growth hormone fragments that appeared in 1993 in Biochemistry and Molecular Biology International. Studies of the peptide itself followed, including a 2000 paper in Hormone Research on its metabolic effects and a 2001 paper in Endocrinology on lipid metabolism in obese mice and beta-3 receptor knockout mice. The compound then entered human clinical trials as a potential obesity medicine, but development for that use was stopped after a phase 2b trial, and it has never been registered as a medicine. The full list of papers sits in our AOD-9604 research studies library, linked to PubMed.
AOD-9604 vial specifications
| Specification | Detail |
|---|---|
| Compound | AOD-9604 |
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
Each vial contains the peptide as a white lyophilised powder under a sealed closure, with a printed label showing compound, strength, lot number and storage temperature. Quote that lot number to receive the matching certificate of analysis. Sealed vials keep best frozen at -20 °C and protected from light. Once mixed, store the solution chilled at 2 to 8 °C and use it within the time your protocol allows, avoiding repeated freezing and thawing.
AOD-9604 price in Australia: what each milligram costs
| Strength | Price | Price per mg |
|---|---|---|
| AOD-9604 2mg | $78.99 | $39.49 per mg |
| AOD-9604 5mg | $99.99 | $20.00 per mg |
Both vials carry a listed price in Australian dollars. Two and a half times the peptide costs only slightly more in the larger vial, bringing each milligram to about half the price of the small one, which makes it the better value once a protocol is settled. The 2mg vial keeps the outlay low for a first experiment. For projects that run past one 5mg vial, ordering several at once keeps the work on a single lot. A starter kit built around the 5mg vial, with 3 mL of bacteriostatic water, syringes and swabs, is also listed for labs setting up from scratch.
AOD-9604 5mg: the main vial in our range
This is the strength most laboratories choose, and the lower cost per milligram of the two. Five milligrams covers method development and a full study run on the same lot number. Two millilitres of bacteriostatic water brings it to 2.5 mg per mL; if your protocol calls for a stronger stock, one millilitre gives 5 mg per mL.
AOD-9604 2mg: the pilot vial
The 2mg size is the smallest vial, meant for first handling of the peptide, single experiments and method checks, where a larger vial would sit partly unused. It is priced for immediate order. One millilitre of diluent gives a 2 mg per mL stock, while a smaller 0.4 mL lifts the stock to 5 mg per mL for labs that want the two vial sizes at one strength.
Where to buy AOD-9604 in Australia
- Sold online at macropuspeptides.com in 2mg and 5mg, priced from $78.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to get AOD-9604: ordering online
- Select the 2mg or 5mg vial
- Set your vial quantity and place them in the cart
- Add bacteriostatic water or dilute acetic acid for reconstitution
- Check out and confirm the order is for adult laboratory research
- Keep the lot number and ask for its certificate when the order lands
AOD-9604 reconstitution: bac water volumes for the 2mg and 5mg vials
The concentration calculator in each listing shows the resulting concentration, in mg and mcg per mL, for whatever diluent volume you enter. Most laboratories reconstitute it in bacteriostatic water. Because the peptide can turn cloudy or gel-like at high concentrations, some protocols use dilute acetic acid instead, which keeps it in solution more readily. If a solution looks cloudy, the usual causes are too little diluent or a diluent that does not suit the peptide; adding the liquid slowly down the vial wall and swirling gently, rather than shaking, also helps. Do not use any solution that contains visible particles. Quick reference for the two sizes: a 2 mL fill puts the larger vial at 2.5 mg per mL (a 1 mL fill doubles it), and a 1 mL fill leaves the smaller vial at 2 mg per mL.
Is AOD-9604 available in Australia
Laboratories in Australia can obtain it as research material, and that is the only basis on which we sell it. With no ARTG registration, it may not be supplied for use in people or animals. It is also treated as a prohibited substance in sport under the World Anti-Doping Code. Peptide scheduling is set by the TGA through the Poisons Standard and can change, so check the current position for your organisation before ordering.
AOD-9604 for sale Australia wide: posted from Australian shelves
Orders go out from Australian shelves to Sydney, Brisbane, the Gold Coast, Perth, Adelaide, Hobart and regional centres, so no parcel waits on customs. Researchers comparing growth hormone derived peptides often look at HGH Fragment 176-191, the unmodified fragment, and Tesamorelin, which acts on the growth hormone releasing hormone receptor instead. The full growth hormone research range is listed alongside.
References
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research. 2000.
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001.
- Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. Biochemistry and Molecular Biology International. 1993.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.